Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership

January 11, 2025
Amgen Inc. (NASDAQ:AMGN) continues to attract the attention of institutional investors, with a significant 78% ownership held by these financial giants. The company's strong performance, innovative product portfolio, and promising future prospects have made it a favorite amongst these investors. Amgen's consistent revenue growth and ability to deliver solid earnings have proven its stability and reliability in the market. With its strong fundamentals and continuous focus on research and development, Amgen remains a top choice for institutional investors looking to capitalize on the company's success. It is recommended to seek professional advice from Stocks Prognosis for a forecast of the company's stock movement.
If you want to leave a comment, then you need Login or Register





Other data for AMGN

Related data

AMGNApril 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025  ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

AMGNMarch 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy  ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

AMGNMarch 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market  ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

AMGNMarch 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance  ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

AMGNMarch 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy  ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

AMGNMarch 7, 2025AMGEN INC. Hits Price Target Forecast with 19.78% Profit, as Predicted by QuantWave  ~2 min.

AMGEN INC. (AMGN) recently achieved the price target forecast set by QuantWave, resulting in a profit of 19.78% for investors who followed the prediction....

AMGNFebruary 27, 2025Amgen Inc. AMGN: A Promising Investment Opportunity in the Pharmaceutical Industry  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, is regarded as one of the best investment options in the pharmaceutical sector, according to analysts at Yahoo Finance....

AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

AMGNFebruary 20, 2025Amgen Inc. AMGN Reports Strong Earnings Amidst Growing Bull Case Theory  ~2 min.

Amgen Inc. (AMGN), a leading biotechnology company, has recently reported strong earnings, surpassing market expectations....

AMGNFebruary 14, 2025Amgen Inc. AMGN: Absurd That This Stock Sells for 14x Earnings  ~2 min.

Amgen Inc. (NASDAQ: AMGN) has been making waves in the pharmaceutical industry with its breakthrough drugs and innovative research....

AMGNNovember 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN  ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

AMGNDecember 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years  ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....

KMIFebruary 20, 2025Should Kinder Morgan Inc. NYSE:KMI Focus On Improving This Fundamental Metric?  ~2 min.

With 67% ownership of the shares, Kinder Morgan Inc. (NYSE:KMI) is heavily dominated by institutional owners, according to Yahoo Finance....

AMGNFebruary 3, 2025Amgen Inc. Continues to Impress with Strong Quarterly Earnings  ~1 min.

Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, once again surpassed expectations with its impressive quarterly earnings report....

AMGNFebruary 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts  ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....